You are here

GSK to produce 1b doses of coronavirus vaccine booster in 2021

file7arnoeldz0p4gsl59ny.jpg
GlaxoSmithKline (GSK) will expand production of vaccine efficacy boosters, or adjuvants, to produce one billion doses in 2021 for use in shots for Covid-19, the British drugmaker said on Thursday.

[BENGALURU] GlaxoSmithKline (GSK) will expand production of vaccine efficacy boosters, or adjuvants, to produce one billion doses in 2021 for use in shots for Covid-19, the British drugmaker said on Thursday.

The London-listed company said it was in talks with governments on backing for...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes